SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950133-04-000442
Filing Date
2004-02-17
Accepted
2004-02-17 10:51:41
Documents
1
Group Members
BIOTECH GROWTH N.V.BIOTECH TARGET N.V.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 w94235asc13gza.txt SC 13G/A 12537
  Complete submission text file 0000950133-04-000442.txt   14647
Mailing Address VODERGASSE 3 SWITZERLAND SCHAFFHAUSEN V8 CH-8300
Business Address VODERGASSE 3 SWITZERLAND SCHAFFHAUSEN V8 CH-8300 411724 59 59
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 0000

Mailing Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650.635.1100
VIROLOGIC INC (Subject) CIK: 0001094961 (see all company filings)

IRS No.: 943234479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-59123 | Film No.: 04604772
SIC: 2835 In Vitro & In Vivo Diagnostic Substances